Reversible cerebral vasoconstriction syndrome (RCVS) is a coined term to express conditions that manifest narrowing of the cerebral arteries. The most common manifestation of a patient with RVCS is severe headache that is thunderclap in presentation, however, some may present with focal neurologic deficits related to the site of edema or vascular occlusion and even cortical manifestation such as seizure. The current treatment for RCVS is still observational, which includes use of calcium channel blockers and intra-arterial vasodilation. In this case report, Cilostazol, a phosphodiesterase 3 inhibitor with a myosin light chain kinase enzyme inhibitor, can be used as a treatment for recanalization of constricted cerebral arteries.
No takes yet. Share an insight, caveat, or question.
A 2022 study studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: